TY  - JOUR

T1  - No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014.

JO  - Int J Cardiol

PY  - 2014/06/27

AU  - Wallentin L

AU  - Becker RC

AU  - Cannon CP

AU  - Held C

AU  - Himmelmann A

AU  - Husted S

AU  - James SK

AU  - Katus HA

AU  - Mahaffey KM

AU  - Pieper KS

AU  - Storey RF et al

ED  - 

DO  - DOI: 10.1016/j.ijcard.2014.06.029

VL  - 176

IS  - 1

SP  - 300

EP  - 302

Y2  - 2024/12/26

ER  -